Found: 36
Select item for more details and to access through your institution.
Endogenous T cells prevent tumor immune escape following adoptive T cell therapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Chemotherapy and oncolytic virotherapy: advanced tactics in the war against cancer.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00145
- By:
- Publication type:
- Article
Chemotherapy and Oncolytic Virotherapy: Advanced Tactics in the War against Cancer.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00145
- By:
- Publication type:
- Article
A Transit Time-Resolved Microflow Cytometry-Based Agglutination Immunoassay for On-Site C-Reactive Protein Detection.
- Published in:
- Micromachines, 2021, v. 12, n. 2, p. 109, doi. 10.3390/mi12020109
- By:
- Publication type:
- Article
A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1754, doi. 10.3390/ijms23031754
- By:
- Publication type:
- Article
Development and applications of oncolytic Maraba virus vaccines.
- Published in:
- Oncolytic Virotherapy, 2018, v. 7, p. 117, doi. 10.2147/OV.S154494
- By:
- Publication type:
- Article
Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy.
- Published in:
- Oncolytic Virotherapy, 2015, v. 4, p. 157, doi. 10.2147/OV.S66079
- By:
- Publication type:
- Article
Autophagy facilitates major histocompatibility complex class I expression induced by IFN-γ in B16 melanoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 2, p. 313, doi. 10.1007/s00262-009-0752-1
- By:
- Publication type:
- Article
Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1295, doi. 10.3390/cancers15041295
- By:
- Publication type:
- Article
Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5590, doi. 10.3390/cancers13215590
- By:
- Publication type:
- Article
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors.
- Published in:
- Communications Biology, 2020, v. 3, n. 1, p. N.PAG, doi. 10.1038/s42003-020-01362-w
- By:
- Publication type:
- Article
T Cells Engineered With Chimeric Antigen Receptors Targeting NKG2D Ligands Display Lethal Toxicity in Mice.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 10, p. 1600, doi. 10.1038/mt.2015.119
- By:
- Publication type:
- Article
Maraba Virus as a Potent Oncolytic Vaccine Vector.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 2, p. 420, doi. 10.1038/mt.2013.249
- By:
- Publication type:
- Article
Immunotherapy-induced CD8<sup>+</sup> T Cells Instigate Immune Suppression in the Tumor.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 1, p. 206, doi. 10.1038/mt.2013.255
- By:
- Publication type:
- Article
HDAC Inhibition Suppresses Primary Immune Responses, Enhances Secondary Immune Responses, and Abrogates Autoimmunity During Tumor Immunotherapy.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 4, p. 887, doi. 10.1038/mt.2012.265
- By:
- Publication type:
- Article
ORFV: A Novel Oncolytic and Immune Stimulating Parapoxvirus Therapeutic.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 6, p. 1148, doi. 10.1038/mt.2011.301
- By:
- Publication type:
- Article
A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer.
- Published in:
- Cancer Gene Therapy, 2003, v. 10, n. 10, p. 755, doi. 10.1038/sj.cgt.7700626
- By:
- Publication type:
- Article
Correction: Estradiol Enhances CD4<sup>+</sup> T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce T<sub>h</sub>17 Responses via an IL-1-Dependent Pathway.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
Estradiol Enhances CD4<sup>+</sup> T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce T<sub>h</sub>17 Responses via an IL-1-Dependent Pathway.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 5, p. 1, doi. 10.1371/journal.ppat.1005589
- By:
- Publication type:
- Article
High Physiological Concentrations of Progesterone Reverse Estradiol-Mediated Changes in Differentiation and Functions of Bone Marrow Derived Dendritic Cells.
- Published in:
- PLoS ONE, 2016, v. 11, n. 4, p. 1, doi. 10.1371/journal.pone.0153304
- By:
- Publication type:
- Article
Combined mTOR Inhibition and OX40 Agonism Enhances CD8<sup>+</sup> T Cell Memory and Protective Immunity Produced by Recombinant Adenovirus Vaccines.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 4, p. 860, doi. 10.1038/mt.2011.281
- By:
- Publication type:
- Article
Engineering Dendritic Cells to Enhance Cancer Immunotherapy.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 5, p. 841, doi. 10.1038/mt.2011.57
- By:
- Publication type:
- Article
Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 2, p. 335, doi. 10.1038/mt.2010.264
- By:
- Publication type:
- Article
Potentiating Cancer Immunotherapy Using an Oncolytic Virus.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 8, p. 1430, doi. 10.1038/mt.2010.98
- By:
- Publication type:
- Article
Processing of Tumor Antigen Differentially Impacts the Development of Helper and Effector CD4<sup>+</sup> T-cell Responses.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 6, p. 1224, doi. 10.1038/mt.2010.30
- By:
- Publication type:
- Article
Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 10, p. 1814, doi. 10.1038/mt.2009.154
- By:
- Publication type:
- Article
Recombinant Vesicular Stomatitis Virus Transduction of Dendritic Cells Enhances Their Ability to Prime Innate and Adaptive Antitumor Immunity.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 8, p. 1465, doi. 10.1038/mt.2009.95
- By:
- Publication type:
- Article
Enhanced Antitumor Immunity Elicited by Dendritic Cell Vaccines Is a Result of Their Ability to Engage Both CTL and IFNγ-producing NK Cells.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 2, p. 411, doi. 10.1038/sj.mt.6300347
- By:
- Publication type:
- Article
On the Role of CD4<sup>+</sup> T Cells in the CD8<sup>+</sup> T-Cell Response Elicited by Recombinant Adenovirus Vaccines.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 5, p. 997, doi. 10.1038/sj.mt.6300130
- By:
- Publication type:
- Article
Development of Cell-Based Tuberculosis Vaccines: Genetically Modified Dendritic Cell Vaccine Is a Much More Potent Activator of CD4 and CD8 T Cells Than Peptide- or Protein-Loaded Counterparts.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 4, p. 766, doi. 10.1016/j.ymthe.2005.10.018
- By:
- Publication type:
- Article
Recombinant Adenovirus Vaccines Can Successfully Elicit CD8<sup>+</sup> T Cell Immunity under Conditions of Extreme Leukopenia.
- Published in:
- Molecular Therapy, 2006, v. 13, n. 2, p. 270, doi. 10.1016/j.ymthe.2005.09.018
- By:
- Publication type:
- Article
Tolerogenic dendritic cells and their potential applications.
- Published in:
- Immunology, 2011, v. 132, n. 3, p. 307, doi. 10.1111/j.1365-2567.2010.03396.x
- By:
- Publication type:
- Article
Epigenetic modification of CSDE1 locus dictates immune recognition of nascent tumorigenic cells.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 681, p. 1, doi. 10.1126/scitranslmed.abq6024
- By:
- Publication type:
- Article
CD4.
- Published in:
- European Journal of Immunology, 2009, v. 39, n. 5, p. 1252, doi. 10.1002/eji.200839152
- By:
- Publication type:
- Article
Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunity.
- Published in:
- Innate Immunity, 2015, v. 21, n. 6, p. 626, doi. 10.1177/1753425915575078
- By:
- Publication type:
- Article